Investigating outcomes after treatment for pulmonary embolism

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the safety and effectiveness of treatments for pulmonary embolism (PE) as determined by a multi-disciplinary pulmonary embolism response team (PERT). It will collect both retrospective and prospective data on treatment outcomes, including advanced modalities like systemic thrombolysis and surgical embolectomy. The study will analyze health-related outcomes of patients treated for acute and chronic PE, focusing on optimizing treatment protocols and institutional algorithms. Data will be gathered from patients treated between 2001 and 2020, with ongoing prospective data collection starting in May 2020.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Consecutive patients with pulmonary embolism matching the criteria for treatment according to the decision of the PERT.
* Written informed consent

Exclusion Criteria:

* High probability of non-adherence to the follow up requirements

Where it's running

• University Hospital Bern - Inselspital
  Bern, Canton of Bern, Switzerland Recruiting
• University Hospital Bern
  Bern, Switzerland Recruiting

Study contacts

• Principal investigator: Stefan Stortecky, MD — Department of Cardiology, Bern University Hospital, University of Bern, Switzerland
• Study coordinator: Stefan Stortecky, MD
• Email: stefan.stortecky@insel.ch
• Phone: +41 31 632 21 11

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• TRiP-cast score test in adults with acute lower-limb injuries requiring immobilization

  This study tests whether the TRiP(cast) score can predict risk of blood clots in adults with acute lower-limb injuries treated as outpatients.

  Recruiting University of Monastir · Monastir · NCT07863115

• Prognostic value of the 2026 AHA/ACC PE classification in ED patients with acute PE

  This study tests whether the 2026 AHA/ACC five-category PE classification helps predict 30-day major adverse pulmonary embolism events in adults with acute PE presenting to the ED.

  Recruiting Marmara University Pendik Training and Research Hospital · Istanbul · NCT07805616

• Right heart dysfunction in acute pulmonary embolism: can echocardiography help predict risk

  This study tests whether transthoracic echocardiography can identify right ventricular dysfunction in adults with acute pulmonary embolism to help gauge risk.

  Recruiting Sohag University · Sohag and 1 other locations · NCT07647497

• Aspiration thrombectomy with the Symphony or Prodigy devices

  This project will try the Symphony and Prodigy aspiration thrombectomy devices to remove arterial, venous, or pulmonary blood clots in adults.

  Recruiting at 13 sites Imperative Care, Inc. · Huntsville, Alabama and 12 other locations · NCT07350499

• PERC and YEARS approaches for diagnosing pulmonary embolism in the emergency department.

  This project will test whether using the PERC score and the YEARS algorithm helps emergency doctors decide which adults need D-dimer blood tests or chest CT scans to diagnose pulmonary embolism.

  Recruiting University Hospital, Strasbourg, France · Strasbourg · NCT07313501

• Reperfusion options for acute pulmonary embolism

  This project will try catheter-directed interventions or systemic thrombolysis in adults with acute pulmonary embolism to see which approach leads to better outcomes.

  Recruiting at 12 sites Sahlgrenska University Hospital · Aarhus and 12 other locations · NCT07003646

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.